Figure 1From: The challenges of long-term follow-up data collection in non-commercial, academically-led breast cancer clinical trials: the UK perspective Growth in UK patients predicted to be in long-term follow-up (>5 years after randomisation). Thirty-four national trials were included in the review. It is expected that approximately 27,000 patients would be in long-term follow-up by the end of 2013.Back to article page